Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 6, 2024American Journal of Dermatopathology

Enfortumab Vedotin Drug Eruption: Cutaneous Adverse Events and Histopathologic Findings

View Full Paper
Ask AI
Bookmark
Share

Authors

FCFiore CasaleGRGretchen M. RothKWKarolyn A. Wanat

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Casale et al. (2024) studied this question.

synapsesocial.com/papers/68e65d18b6db6435875eb674https://doi.org/10.1097/dad.0000000000002750
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Enfortumab vedotin‐induced cutaneous eruption: Ring mitotic figures as a distinctive histopathologic feature2024 · 14 citations
  2. 2Enfortumab Vedotin–Related Cutaneous Adverse Events: Two Cases Highlighting Ring Mitosis and Severity‐Guided Management2026 · 1 citations
  3. 3Dermatopathological Findings of an Erythema Multiforme‐Like Drug Eruption During Enfortumab Vedotin Plus Pembrolizumab Therapy for Metastatic Urothelial Carcinoma: A Case Report2026 · 1 citations
  4. 4Enfortumab vedotin–related cutaneous toxicity correlates with overall survival in patients with urothelial cancer: a retrospective experience2024 · 13 citations
  5. 5One Man’s Meat Is Another Man’s Poison: High Incidence of Severe Cutaneous Drug Reactions Induced by Enfortumab Vedotin2025 · 4 citations